149 related articles for article (PubMed ID: 37833979)
1. Nuciferine Inhibits Oral Squamous Cell Carcinoma Partially through Suppressing the STAT3 Signaling Pathway.
Xie JR; Chen XJ; Zhou G
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833979
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
3. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
[TBL] [Abstract][Full Text] [Related]
4. Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling.
Yang JG; Lu R; Ye XJ; Zhang J; Tan YQ; Zhou G
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085115
[TBL] [Abstract][Full Text] [Related]
5. Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
Li QH; Sui LP; Zhao YH; Chen BG; Li J; Ma ZH; Hu ZH; Tang YL; Guo YX
Tohoku J Exp Med; 2021 May; 254(1):17-23. PubMed ID: 34011804
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
7. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
8. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
9. Licochalcone D directly targets JAK2 to induced apoptosis in human oral squamous cell carcinoma.
Seo JH; Choi HW; Oh HN; Lee MH; Kim E; Yoon G; Cho SS; Park SM; Cho YS; Chae JI; Shim JH
J Cell Physiol; 2019 Feb; 234(2):1780-1793. PubMed ID: 30070696
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of toosendanin on oral squamous cell carcinoma via suppression of p-STAT3.
Wu Y; Chen L; Feng C; Wang T; He S; Zheng D; Lin L
BMC Oral Health; 2023 Nov; 23(1):846. PubMed ID: 37946196
[TBL] [Abstract][Full Text] [Related]
11. 2-O-Methylmagnolol Induces Apoptosis and Inhibits IL-6/STAT3 Signaling in Oral Squamous Cell Carcinoma.
Wang TH; Fang JY; Wu SJ; Liu YW; Chan CW; Chuang SY; Chen CY
Cell Physiol Biochem; 2018; 50(3):883-892. PubMed ID: 30355952
[TBL] [Abstract][Full Text] [Related]
12. STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma.
Jiang M; Li B
Cells; 2022 Oct; 11(19):. PubMed ID: 36231093
[TBL] [Abstract][Full Text] [Related]
13. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
14. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
[TBL] [Abstract][Full Text] [Related]
15. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
Zhou X; Ren Y; Liu A; Han L; Zhang K; Li S; Li P; Li P; Kang C; Wang X; Zhang L
Oncol Rep; 2014 May; 31(5):2173-80. PubMed ID: 24676554
[TBL] [Abstract][Full Text] [Related]
16. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.
Chi J; Liu Y; Yang L; Yang J
J Oral Maxillofac Surg; 2022 Aug; 80(8):1408-1423. PubMed ID: 35568099
[TBL] [Abstract][Full Text] [Related]
17. Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.
Wang Y; Guo W; Li Z; Wu Y; Jing C; Ren Y; Zhao M; Kong L; Zhang C; Dong J; Shuang Y; Sun S; Chen J; Wu C; Qiao Y; Qu X; Wang X; Zhang L; Jin R; Zhou X
Int J Oncol; 2018 Apr; 52(4):1149-1164. PubMed ID: 29532870
[TBL] [Abstract][Full Text] [Related]
18. Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.
Mallery SR; Wang D; Santiago B; Pei P; Schwendeman SP; Nieto K; Spinney R; Tong M; Koutras G; Han B; Holpuch A; Lang J
Cancer Prev Res (Phila); 2017 Jan; 10(1):76-88. PubMed ID: 27756753
[TBL] [Abstract][Full Text] [Related]
19. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
20. M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.
You Y; Tian Z; Du Z; Wu K; Xu G; Dai M; Wang Y; Xiao M
J Exp Clin Cancer Res; 2022 Jan; 41(1):10. PubMed ID: 34991668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
